RhumbLine Advisers’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-606,023
| Closed | -$537K | – | 2988 |
|
2022
Q4 | $537K | Buy |
606,023
+48,432
| +9% | +$42.9K | ﹤0.01% | 2431 |
|
2022
Q3 | $875K | Buy |
557,591
+34,728
| +7% | +$54.5K | ﹤0.01% | 2209 |
|
2022
Q2 | $1.05M | Buy |
522,863
+213,161
| +69% | +$428K | ﹤0.01% | 2115 |
|
2022
Q1 | $722K | Buy |
309,702
+5,297
| +2% | +$12.3K | ﹤0.01% | 2270 |
|
2021
Q4 | $1.42M | Buy |
304,405
+5,653
| +2% | +$26.3K | ﹤0.01% | 2063 |
|
2021
Q3 | $2.28M | Buy |
298,752
+7,335
| +3% | +$56K | ﹤0.01% | 1837 |
|
2021
Q2 | $2.82M | Buy |
291,417
+8,903
| +3% | +$86.3K | ﹤0.01% | 1772 |
|
2021
Q1 | $2.34M | Sell |
282,514
-11,518
| -4% | -$95.2K | ﹤0.01% | 1841 |
|
2020
Q4 | $2.01M | Buy |
294,032
+44,853
| +18% | +$306K | ﹤0.01% | 1844 |
|
2020
Q3 | $2.78M | Sell |
249,179
-14,082
| -5% | -$157K | ﹤0.01% | 1507 |
|
2020
Q2 | $1.65M | Buy |
263,261
+100,296
| +62% | +$630K | ﹤0.01% | 1835 |
|
2020
Q1 | $300K | Sell |
162,965
-809
| -0.5% | -$1.49K | ﹤0.01% | 2408 |
|
2019
Q4 | $554K | Buy |
163,774
+6,998
| +4% | +$23.7K | ﹤0.01% | 2316 |
|
2019
Q3 | $336K | Buy |
156,776
+1,140
| +0.7% | +$2.44K | ﹤0.01% | 2523 |
|
2019
Q2 | $416K | Buy |
155,636
+16,188
| +12% | +$43.3K | ﹤0.01% | 2438 |
|
2019
Q1 | $662K | Buy |
139,448
+1,811
| +1% | +$8.6K | ﹤0.01% | 2201 |
|
2018
Q4 | $330K | Buy |
137,637
+54,072
| +65% | +$130K | ﹤0.01% | 2491 |
|
2018
Q3 | $368K | Buy |
83,565
+3,873
| +5% | +$17.1K | ﹤0.01% | 2410 |
|
2018
Q2 | $574K | Buy |
+79,692
| New | +$574K | ﹤0.01% | 2242 |
|
2017
Q2 | – | Sell |
-34,686
| Closed | -$137K | – | 2972 |
|
2017
Q1 | $137K | Buy |
34,686
+2,686
| +8% | +$10.6K | ﹤0.01% | 2736 |
|
2016
Q4 | $157K | Buy |
32,000
+1,725
| +6% | +$8.46K | ﹤0.01% | 2729 |
|
2016
Q3 | $234K | Buy |
30,275
+300
| +1% | +$2.32K | ﹤0.01% | 2602 |
|
2016
Q2 | $168K | Buy |
29,975
+575
| +2% | +$3.22K | ﹤0.01% | 2811 |
|
2016
Q1 | $158K | Buy |
29,400
+230
| +0.8% | +$1.24K | ﹤0.01% | 2810 |
|
2015
Q4 | $254K | Buy |
29,170
+4,110
| +16% | +$35.8K | ﹤0.01% | 2672 |
|
2015
Q3 | $210K | Buy |
25,060
+1,110
| +5% | +$9.3K | ﹤0.01% | 2763 |
|
2015
Q2 | $422K | Buy |
+23,950
| New | +$422K | ﹤0.01% | 2443 |
|